http://www.unboundmedicine.com/medline/ebm/research/sorafenibUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19894099/full_citation/Sorafenib_induced_hand_foot_skin_reaction:_a_Koebner_phenomenonSibaud V, Delord J, Chevreau C 
Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon? [JOURNAL ARTICLE]
Target Oncol 2009 Nov 7.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891127/full_citation/Novel_antiangiogenic_agents_in_the_treatment_of_refractory_renal_cell_carcinoma_Sonpavde G, Hutson TE 
Novel antiangiogenic agents in the treatment of refractory renal cell carcinoma. [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S29-36.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891126/full_citation/Vascular_endothelial_growth_factor_pathway_targeted_therapy_as_initial_systemic_treatment_of_patients_with_renal_cancer_Chung EK, Stadler WM 
Vascular endothelial growth factor pathway-targeted therapy as initial systemic treatment of patients with renal cancer. [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S22-8.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891125/full_citation/What_role_do_combinations_of_interferon_and_targeted_agents_play_in_the_first_line_therapy_of_metastatic_renal_cell_carcinomaBukowski RM 
What role do combinations of interferon and targeted agents play in the first-line therapy of metastatic renal cell carcinoma? [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S14-21.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891124/full_citation/Current_algorithms_and_prognostic_factors_in_the_treatment_of_metastatic_renal_cell_carcinoma_Molina AM, Motzer RJ 
Current algorithms and prognostic factors in the treatment of metastatic renal cell carcinoma. [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S7-13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890962/full_citation/Where_does_the_combination_of_sorafenib_and_interferon_in_renal_cell_carcinoma_standFlaherty KT 
Where does the combination of sorafenib and interferon in renal cell carcinoma stand? [JOURNAL ARTICLE]
Cancer 2009 Nov 4.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890601/full_citation/Medical_treatments:_in_association_or_alone_their_roles_and_their_future_perspectives_:_The_Western_experience_Reig M, Bruix J 
Medical treatments: in association or alone, their roles and their future perspectives : The Western experience. [JOURNAL ARTICLE]
J Hepatobiliary Pancreat Surg 2009 Nov 5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19889617/full_citation/Nephrotic_syndrome_caused_by_the_angiogenesis_inhibitor_sorafenib_Overkleeft EN, Goldschmeding R, van Reekum F, et al. 
Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884542/full_citation/Sorafenib_Induced_Bilateral_Osteonecrosis_of_Femoral_Heads_Guillet M, Walter T, Scoazec JY, et al. 
Sorafenib-Induced Bilateral Osteonecrosis of Femoral Heads. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19878585/full_citation/Proliferation_and_survival_molecules_implicated_in_the_inhibition_of_BRAF_pathway_in_thyroid_cancer_cells_harbouring_different_genetic_mutations_Preto A, Goncalves J, Rebocho AP, et al. 
Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. [JOURNAL ARTICLE]
BMC Cancer 2009 Oct 31; 9(1):387.
Abstract | Full Citation | Publisher Full Text | Find Related Articles